Dashboard
Manage Tickers

SGMTSagimet Biosciences Inc.

Nasdaq www.sagimet.com


$ 4.62 $ -0.13 (-2.74 %)    

Friday, 17-May-2024 15:59:13 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 451.63 $ -0.22 (-0.05 %)
DIA $ 399.76 $ 0.74 (0.19 %)
SPY $ 529.24 $ 0.76 (0.14 %)
TLT $ 91.40 $ -0.62 (-0.67 %)
GLD $ 223.63 $ 3.63 (1.65 %)
$ 4.62
$ 4.59
$ 0.00 x 0
$ 0.00 x 0
$ 4.56 - $ 4.67
$ 2.13 - $ 20.71
269,303
na
134.16M
$ 4.81
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-15-2024 03-31-2024 10-Q
2 03-25-2024 12-31-2023 10-K
3 11-13-2023 09-30-2023 10-Q
4 08-21-2023 06-30-2023 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

alibaba-to-rally-over-13-here-are-10-top-analyst-forecasts-for-thursday
Alibaba To Rally Over 13%? Here Are 10 Top...
05/16/2024 12:20:20

sagimet-biosciences-to-host-virtual-investor-and-analyst-day-on-inhibiting-fatty-acid-synthase-fasn-to-reduce-liver-fat-inflammation-and-fibrosis-in-mash-on-may-23-2024
Sagimet Biosciences to Host Virtual Invest...
05/16/2024 12:02:45

Sagimet Biosciences Inc. ((Sagimet, NASDAQ:SGMT), a clinical-stage biopharmaceutical company developing novel fatty acid syntha...

goldman-sachs-maintains-buy-on-sagimet-biosciences-lowers-price-target-to-23
Goldman Sachs Maintains Buy on Sagimet Bio...
05/16/2024 11:47:06

Goldman Sachs analyst Andrea Tan maintains Sagimet Biosciences (NASDAQ:SGMT) with a Buy and lowers the price target from $27...

hc-wainwright--co-reiterates-buy-on-sagimet-biosciences-maintains-32-price-target
HC Wainwright & Co. Reiterates Buy on Sagi...
05/16/2024 10:32:06

HC Wainwright & Co. analyst Ed Arce reiterates Sagimet Biosciences (NASDAQ:SGMT) with a Buy and maintains $32 price target.

sagimet-announces-oral-presentation-of-data-from-the-phase-2b-fascinate-2-study-of-denifanstat-in-mash-at-easl-international-liver-congress-2024
Sagimet Announces Oral Presentation Of Dat...
05/07/2024 12:05:32

Sagimet Biosciences Inc. ((Sagimet, NASDAQ:SGMT), a clinical-stage biopharmaceutical company developing novel fatty acid syntha...

sagimet-biosciences-announces-appointment-of-thierry-chauche-as-chief-financial-officer-effective-may-6-2024
Sagimet Biosciences Announces Appointment ...
05/06/2024 12:03:53

Sagimet Biosciences Inc. ((Sagimet, NASDAQ:SGMT), a clinical-stage biopharmaceutical company developing novel fatty acid syntha...

hc-wainwright--co-initiates-coverage-on-sagimet-biosciences-with-buy-rating-announces-price-target-of-32
HC Wainwright & Co. Initiates Coverage On ...
05/02/2024 10:55:37

HC Wainwright & Co. analyst Ed Arce initiates coverage on Sagimet Biosciences (NASDAQ:SGMT) with a Buy rating and announ...

sagimet-biosciences-announces-completion-of-phase-1-hepatic-impairment-study-with-fasn-inhibitor-denifanstat
Sagimet Biosciences Announces Completion O...
03/27/2024 20:19:21

Sagimet Biosciences Inc. ((Sagimet, NASDAQ:SGMT), a clinical-stage biopharmaceutical company developing novel fatty acid syntha...

goldman-sachs-maintains-buy-on-sagimet-biosciences-lowers-price-target-to-27
Goldman Sachs Maintains Buy on Sagimet Bio...
03/26/2024 16:54:35

Goldman Sachs analyst Andrea Tan maintains Sagimet Biosciences (NASDAQ:SGMT) with a Buy and lowers the price target from $37...

why-landos-biopharma-shares-are-trading-higher-by-over-170-here-are-other-stocks-moving-in-mondays-mid-day-session
Why Landos Biopharma Shares Are Trading Hi...
03/25/2024 18:44:08

Shares of Landos Biopharma, Inc. (NASDAQ: LABP) rose sharply during Monday’s session following acquisition news.

12-health-care-stocks-moving-in-mondays-intraday-session
12 Health Care Stocks Moving In Monday's I...
03/25/2024 17:30:58

leerink-partners-initiates-coverage-on-sagimet-biosciences-with-outperform-rating-announces-price-target-of-26
Leerink Partners Initiates Coverage On Sag...
03/25/2024 10:46:33

Leerink Partners analyst Thomas Smith initiates coverage on Sagimet Biosciences (NASDAQ:SGMT) with a Outperform rating and a...

sagimet-biosciences-fy-eps-266-may-not-be-comparable-to-2591-estimate-sales-200k-anticipated-cash-runway-through-2025-by-completing-follow-on-offering-in-january-2024-for-1047m-and-cash-cash-equivalents-and-marketable-securities-of-949m
Sagimet Biosciences FY EPS $(2.66) May Not...
03/25/2024 10:19:19

12-health-care-stocks-moving-in-fridays-after-market-session
12 Health Care Stocks Moving In Friday's A...
02/16/2024 21:31:07

jmp-securities-maintains-market-outperform-on-sagimet-biosciences-lowers-price-target-to-46
JMP Securities Maintains Market Outperform...
02/07/2024 16:25:21

JMP Securities analyst Jonathan Wolleben maintains Sagimet Biosciences (NASDAQ:SGMT) with a Market Outperform and lowers the...

why-fmc-shares-are-trading-lower-by-around-10-here-are-other-stocks-moving-in-tuesdays-mid-day-session
Why FMC Shares Are Trading Lower By Around...
02/06/2024 18:17:47

Shares of FMC Corporation (NYSE: FMC) fell sharply during Tuesday’s session after the company reported worse-than-expected fo...

12-health-care-stocks-moving-in-tuesdays-intraday-session
12 Health Care Stocks Moving In Tuesday's ...
02/06/2024 17:31:29

why-intel-shares-are-trading-lower-by-over-10-here-are-other-stocks-moving-in-fridays-mid-day-session
Why Intel Shares Are Trading Lower By Over...
01/26/2024 18:17:28

Shares of Intel Corporation (NASDAQ: INTC) fell sharply during Friday’s session. Intel reported upbeat results for its fourth q...

12-health-care-stocks-moving-in-fridays-pre-market-session
12 Health Care Stocks Moving In Friday's P...
01/26/2024 13:05:58

kla-reports-q2-results-joins-visa-western-digital-and-other-big-stocks-moving-lower-in-fridays-pre-market-session
KLA Reports Q2 Results, Joins Visa, Wester...
01/26/2024 09:58:11

U.S. stock futures were lower this morning, with the Dow futures falling around 100 points on Friday.

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION